StockData
Sight Sciences, Inc. logo

Sight Sciences, Inc. (SGHT) stock

SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30164% above fair value
$10.49−0.10 (-0.94%)

Close on Nov 17, 2026Market cap $577.87MP/E –Yield –

Sight Sciences operating margin

Operating margin is operating income as a percentage of revenue.

Sight Sciences's operating margin for the twelve months ending Jun 30, 2026 was -33.4%. For fiscal 2025 it was -48.0%, against -63.3% the year before. The highest annual figure on record is -48.0% in fiscal 2025.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-48.0%+15.3
FY2024Dec 31, 2024-63.3%+7.4
FY2023Dec 31, 2023-70.7%+47.0
FY2022Dec 31, 2022-117.7%−12.5
FY2021Dec 31, 2021-105.2%+11.3
FY2020Dec 31, 2020-116.5%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-16.6%+43.0
Q1 FY2026Mar 31, 2026-63.0%+16.1
Q4 FY2025Dec 31, 2025-18.0%+44.5
Q3 FY2025Sep 30, 2025-39.7%+16.0
Q2 FY2025Jun 30, 2025-59.6%−0.4
Q1 FY2025Mar 31, 2025-79.2%−2.7
Q4 FY2024Dec 31, 2024-62.5%−3.3
Q3 FY2024Sep 30, 2024-55.7%+11.3
Q2 FY2024Jun 30, 2024-59.2%+5.5
Q1 FY2024Mar 31, 2024-76.4%+16.9
Q4 FY2023Dec 31, 2023-59.3%+23.8
Q3 FY2023Sep 30, 2023-67.0%+49.9
Q2 FY2023Jun 30, 2023-64.7%+68.0
Q1 FY2023Mar 31, 2023-93.3%+55.8
Q4 FY2022Dec 31, 2022-83.0%+17.2
Q3 FY2022Sep 30, 2022-117.0%−9.9
Q2 FY2022Jun 30, 2022-132.7%−44.3
Q1 FY2022Mar 31, 2022-149.1%−14.2
Q4 FY2021Dec 31, 2021-100.2%−6.4
Q3 FY2021Sep 30, 2021-107.1%−22.1
Q2 FY2021Jun 30, 2021-88.4%+131.2
Q1 FY2021Mar 31, 2021-135.0%–
Q4 FY2020Dec 31, 2020-93.8%–
Q3 FY2020Sep 30, 2020-85.0%–
Q2 FY2020Jun 30, 2020-219.6%–

More Sight Sciences figures

See a number that looks wrong?